Vimarsana
Biggest News Aggregation in the World

Sunrise 1 News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Sunrise 1. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Sunrise 1 Today - Breaking & Trending Today

TAR-200 Monotherapy Has 82.8% Complete Response Rate in BCG-Unresponsive HR-NMIBC - Vimarsana News

TAR-200 Monotherapy Has 82.8% Complete Response Rate in BCG-Unresponsive HR-NMIBC

Published: May 4, 2024

Updated findings from SunRISe-1 also showed that all but 1 responder achieved complete response within 12 weeks of treatment with the targeted gemcitabine delivery system.

Source: ajmc.com
Related Topics:
United StatesJoseph JacobBernard ChantalEuropean Society For Medical OncologyAmerican Urological AssociationEuropean Association Of UrologyBacillus Calmette GuUpstate MedicalEuropean SocietyMedical OncologyEuropean AssociationBacillus CalmetteSunrise 1Tar 200Bladder Cancer
ESMO 2023 Insights: SunRISe-1 Study of TAR-200 in BCG-Unresponsive Bladder Cancer - Vimarsana News

ESMO 2023 Insights: SunRISe-1 Study of TAR-200 in BCG-Unresponsive Bladder Cancer

Published: December 11, 2023

Siamak Daneshmand, MD, discusses the results of SunRISe-1 study of TAR-200, an intravesical drug delivery system, in patients with BCG-unresponsive HR NMIBC from ESMO 2023.

Source: ajmc.com
Related Topics:
Sia DaneshmandPretzel DeviceOsmotic PumpSunrise 1Sunrise 2Sunrise 3Sunrise 4Pd 1Mechanisms Of ReleaseTar 210Targeted Sustained TherapySustained ReleaseGlobal TrialsTar 200Chromatin Regulators Crs